These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 26207746)
1. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1). Yang SM; Yasgar A; Miller B; Lal-Nag M; Brimacombe K; Hu X; Sun H; Wang A; Xu X; Nguyen K; Oppermann U; Ferrer M; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ J Med Chem; 2015 Aug; 58(15):5967-78. PubMed ID: 26207746 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity. Yang SM; Martinez NJ; Yasgar A; Danchik C; Johansson C; Wang Y; Baljinnyam B; Wang AQ; Xu X; Shah P; Cheff D; Wang XS; Roth J; Lal-Nag M; Dunford JE; Oppermann U; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ J Med Chem; 2018 Jun; 61(11):4883-4903. PubMed ID: 29767973 [TBL] [Abstract][Full Text] [Related]
3. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity. Ma Z; Jiang L; Li B; Liang D; Feng Y; Liu L; Jiang C Bioorg Med Chem; 2021 Sep; 46():116352. PubMed ID: 34403955 [TBL] [Abstract][Full Text] [Related]
4. Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors. Li B; Yang K; Liang D; Jiang C; Ma Z Eur J Med Chem; 2021 Jan; 209():112940. PubMed ID: 33328099 [TBL] [Abstract][Full Text] [Related]
5. Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1. Morgan CA; Hurley TD Chem Biol Interact; 2015 Jun; 234():29-37. PubMed ID: 25450233 [TBL] [Abstract][Full Text] [Related]
6. Discovery of coumarin-based selective aldehyde dehydrogenase 1A1 inhibitors with glucose metabolism improving activity. Liang D; Fan Y; Yang Z; Zhang Z; Liu M; Liu L; Jiang C Eur J Med Chem; 2020 Feb; 187():111923. PubMed ID: 31816557 [TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation. Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489 [TBL] [Abstract][Full Text] [Related]
8. Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation. Makia NL; Bojang P; Falkner KC; Conklin DJ; Prough RA Chem Biol Interact; 2011 May; 191(1-3):278-87. PubMed ID: 21256123 [TBL] [Abstract][Full Text] [Related]
9. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity. Parajuli B; Georgiadis TM; Fishel ML; Hurley TD Chembiochem; 2014 Mar; 15(5):701-12. PubMed ID: 24677340 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives. Buchman CD; Hurley TD J Med Chem; 2017 Mar; 60(6):2439-2455. PubMed ID: 28219011 [TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Koppaka V; Thompson DC; Chen Y; Ellermann M; Nicolaou KC; Juvonen RO; Petersen D; Deitrich RA; Hurley TD; Vasiliou V Pharmacol Rev; 2012 Jul; 64(3):520-39. PubMed ID: 22544865 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells. Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995 [TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer. Chen Y; Orlicky DJ; Matsumoto A; Singh S; Thompson DC; Vasiliou V Biochem Biophys Res Commun; 2011 Feb; 405(2):173-9. PubMed ID: 21216231 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis of 1,3-dimethylpyrimidine-2,4-diones as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity. Ma Z; Jiang L; Li G; Liang D; Li L; Liu L; Jiang C Bioorg Chem; 2020 Aug; 101():103971. PubMed ID: 32480173 [TBL] [Abstract][Full Text] [Related]
15. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors. Morgan CA; Hurley TD J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases. Khanna M; Chen CH; Kimble-Hill A; Parajuli B; Perez-Miller S; Baskaran S; Kim J; Dria K; Vasiliou V; Mochly-Rosen D; Hurley TD J Biol Chem; 2011 Dec; 286(50):43486-94. PubMed ID: 22021038 [TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor. Gowda K; Raza A; Vangala V; Lone NA; Lin JM; Singh JK; Srivastava SK; Schell TD; Robertson GP; Amin S; Sharma AK Molecules; 2024 Jun; 29(13):. PubMed ID: 38999066 [TBL] [Abstract][Full Text] [Related]
18. Insight into the Structural Requirements of Theophylline-Based Aldehyde Dehydrogenase lAl (ALDHlAl) Inhibitors Through Multi-QSAR Modeling and Molecular Docking Approaches. Abdul Amin S; Adhikari N; Gayen S; Jha T Curr Drug Discov Technol; 2016; 13(2):84-100. PubMed ID: 27132720 [TBL] [Abstract][Full Text] [Related]
19. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Moreb JS; Ucar D; Han S; Amory JK; Goldstein AS; Ostmark B; Chang LJ Chem Biol Interact; 2012 Jan; 195(1):52-60. PubMed ID: 22079344 [TBL] [Abstract][Full Text] [Related]
20. Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. Huddle BC; Grimley E; Buchman CD; Chtcherbinine M; Debnath B; Mehta P; Yang K; Morgan CA; Li S; Felton J; Sun D; Mehta G; Neamati N; Buckanovich RJ; Hurley TD; Larsen SD J Med Chem; 2018 Oct; 61(19):8754-8773. PubMed ID: 30221940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]